CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Next-generation sequencing (NGS) in 936 patients (pts) with advanced cancers to prospectively guide clinical trial selection: The Sarah Cannon Research Institute (SCRI) experience.
Authors
Cassie M Lane
David R. Spigel
+10Â more
Denise A. Yardley
Hendrik-Tobias Arkenau
Howard A. Burris
James Prescott
Jeffrey R. Infante
Johanna C. Bendell
Pranil Chandra
Suzanne Fields Jones
Todd Michael Bauer
Zeqiang Ma
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 25/10/2020